Loading…
The company announced the achievement on November 11, 2025.
Quoin Pharmaceuticals, Ltd. announced on November 11, 2025, that it has achieved the target loading concentrations for its two topical rapamycin delivery technologies. The concentrations achieved were 4% w/w and 5% w/w.
The announcement did not include any filings or comparators. The company's free float stands at 16,306,200 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.